Amunix

Investments

3

Lead Investments

0

Amunix Operating Inc is a biopharmaceutical company focused on the discovery, design, and development of novel biologics, protein, and peptide therapeutics. The company was acquired by Sanofi, which added a promising pipeline of T-cell engagers and cytokine therapies to its portfolio.

Founded 2006

North America, United States

11-50

amunix.com